Fenestrated and branched endovascular aneurysm repair (FEVAR/BEVAR) using supra-coeliac sealing zones and four-vessel designs is safe can be performed with “excellent” early outcomes according to data from a study presented at the Vascular Annual Meeting (9–11 June, National Harbor, USA).
Initial results from the STABLE II study indicate that a covered stent graft with a bare metal stent is safe and effective in treating acute, complicated type B aortic dissection. The results were presented at the Vascular Annual Meeting (9–11 June, National Harbor, USA) by Joseph Lombardi, Cooper University Hospital, Camden, USA.
Primary safety and efficacy endpoints for the Nellix system (Endologix) investigational device exemption (IDE) trial have been achieved at one year, with “very low morbidity and mortality and high procedural and treatment success,” according to Jeffrey Carpenter, Cooper Medical School of Rowan University, Camden, USA, at the Vascular Annual Meeting (9–11 June, National Harbor, USA).
Essential Medical has received CE mark approval for Manta, the company’s large bore vascular closure device.
Ash Verma, Clearwater, USA, writes how last year, he happened upon a routine case that struck him as both totally unremarkable and absolutely extraordinary. A 69-year-old female patient presented with one week of swelling and pain in her left arm, notable for a history of lung carcinoma that had, five months earlier, prompted placement of a left subclavian chest port. An ultrasound confirmed occlusive deep-vein thrombosis (DVT) in the patient’s left basilic, brachial, axillary and subclavian veins. A venogram detailed that the occlusive thrombus reached the level of the subclavian vein port catheter entry site.
FlowAid Medical Technologies has received CE mark approval for its FA100 SCCD sequential contraction compression device.
BTG has announced that it has obtained CE mark from the Notified Body British Standards Institution (BSI) following completion of the reclassification of DC Bead and DC Bead M1 as class III medical devices.
According to a new study by the Harvey L. Neiman Health Policy Institute, the last 13 years have seen a substantial growth in the ordering of computed tomography angiography (CTA) examinations in the Medicare population, particularly in the emergency department setting.
Penumbra has launched its new ACE 68 reperfusion catheter in the USA. The catheter is part of the Penumbra System, and was launched at the Society of NeuroInterventional Surgery (SNIS) 13th Annual Meeting in Boston, USA.
The US Food and Drug Administration (FDA) has released a draft guidance document entitled “Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices”.
Speaking at the World Conference on Interventional Oncology (WCIO; 9–12 June, Boston, USA), George Carberry (University of Wisconsin School of Medicine and Public Health, Madison, WI, USA) reported that positioning an antenna at least 5mm away from the heart when performing microwave ablation of the lung is associated with a significant reduction in arrhythmia and cardiac tissue injury compared with positioning the antenna nearer to the heart.
AV Medical has announced the commencement of cases in the US with its Chameleon percutaneous transluminal angioplasty balloon catheter.
The results from a prospective, randomised study, published online ahead of print in the Journal of Vascular and Interventional Radiology (JVIR) suggest that stent graft use provides a sustained, greater than two-fold advantage over angioplasty in treatment area and overall access patency in arteriovenous access graft stenosis.
New data presented by Volker Heinemann in an oral abstract session at the European Society of Medical Oncology’s 18th World Congress on Gastrointestinal Cancer suggest that patients with liver-dominant mCRC treated first-line with the combination of mFOLFOX6 and SIR-Spheres Y-90 resin microspheres in the recently published SIRFLOX study experienced a much more profound response to treatment in the liver than those who received chemotherapy alone.
SRS Medical Systems has announced that it has received CE mark approval for use of its Spanner temporary prostate stent in the European Economic Area (EEA). Spanner is an alternative to both indwelling (Foley) and intermittent urinary catheters for male patients with bladder outlet obstruction.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos